Correspondence “Optimising the unilateral DIEP flap breast reconstruction: A United Kingdom-Netherlands multi-centre comparative study” Authors: Benedetto Longo, Lisa Vannucchi, Martina Giacalone, Gennaro D’Orsi, Valerio Cervelli Published: 2026 We read with considerable interest the article “Optimising the unilateral DIEP flap breast reconstruction: A United Kingdom–Netherlands multi-centre comparative study” by Jacobi et al. The authors should be commended for addressing one of the most relevant and unresolved issues in contemporary microsurgical breast reconstruction: the interplay between operative efficiency, perioperative pathways, and postoperative outcomes.1 However, while the manuscript provides valuable comparative insights, it also unintentionally exposes a fundamental limitation that continues to characterize many current DIEP pathways—namely, the persistence of structurally inefficient surgical models and an over-reliance on traditional perioperative assumptions. The most striking finding of the study is the significant disparity in operative time between the two cohorts, with procedures lasting average 464 min in the UK versus 330 min in the Netherlands (p < 0.001). This difference of more than two hours is not merely a technical variation, but rather a determinant factor influencing postoperative recovery. Indeed, the authors themselves demonstrate that operative time is directly associated with both early and late complications, with clinically meaningful increases when expressed per hour (OR up to 1.71 per 60 min). In this context, it is difficult to overlook the central paradox of the study: the cohort utilizing an ERAS protocol (UK) still exhibited significantly longer operative times and comparable complication rates (61%vs 56%), despite a shorter length of stay (4.8 vs 5.9 days). This raises a critical issue—whether ERAS protocols, as currently implemented, are addressing the true drivers of postoperative recovery, or merely compensating for inefficiencies inherent to the surgical process itself. From our perspective, the manuscript reinforces a concept that is often underestimated: operative efficiency is not a secondary parameter, but the cornerstone of recovery in DIEP flap surgery. Prolonged operative duration directly translates into increased physiological stress, greater tissue trauma, higher fluid shifts, and delayed mobilisation—factors that no amount of postoperative analgesia or protocolisation can fully mitigate. Equally relevant is the observation that the Netherlands cohort, which did not formally implement ERAS pathways, achieved significantly shorter operative times through a co-surgeon model and lean optimisation strategies. This suggests that organisational and technical factors may exert a greater impact on outcomes than perioperative protocols alone. Notably, both cohorts reported prolonged hospitalisation (4.8–5.9 days), which remains distant from what is currently achievable in optimized microsurgical pathways. In our experience, the implementation of a streamlined, standardised surgical workflow—combined with elimination of unnecessary perioperative interventions, including routine opioid use and regional blocks—allows mobilisation within 24 h and discharge within 24–48 h, without increased complication rates.2 Therefore, the key message emerging from this study is not simply that ERAS reduces length of stay, but that ERAS alone is insufficient when not accompanied by true operative optimisation. In addition, the manuscript continues to frame recovery within a traditional paradigm where analgesic strategies and postoperative care pathways are central. However, the absence of any meaningful discussion regarding opioid elimination, simplification of analgesia, or the role of minimally pharmacologic pathways reflects a persistent gap in the evolution of ERAS concepts in microsurgical reconstruction. In our opinion, the future direction of DIEP surgery should move beyond the incremental refinement of perioperative protocols and instead focus on three fundamental pillars: drastic reduction of operative time through team-based surgery, simplification of perioperative management with avoidance of unnecessary pharmacologic interventions and proactively facilitated early mobilisation with expectation-driven recovery.3, 4, 5 In conclusion, while this study provides valuable comparative data, it ultimately highlights that the true limitation of current ERAS pathways is not their structure, but their incomplete integration with surgical efficiency. Without addressing operative time and workflow optimisation, any ERAS protocol risks remaining a compensatory rather than transformative strategy. Funding No funding was received for this research. Ethical approval Ethical approval and consent were not required. Declaration of competing interest All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.